Raj Satyanarayana, M.D.

Closed for Enrollment

• A Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Once-Daily Oral Avatrombopag for the Treatment of Adults with Thrombocytopenia Associated with Liver Disease Prior to an Elective Procedure Jacksonville, Fla.

  The purpose of this study is to evaluate the safety and effectiveness of using avatrombopag to treat adults with thrombocytopenia associated with liver disease prior to an elective procedure, to reduce the need for platelet transfusions or any rescue procedure for bleeding due to procedural and post-procedural bleeding complications.